Chevy Chase Trust
XERS icon

Chevy Chase Trust’s Xeris Biopharma Holdings XERS Stock Holding History

Chevy Chase Trust’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-51,243
Closed -$239K – 643
2025
Q2 		$239K Hold
51,243
– – ﹤0.01% 620
2025
Q1 		$281K Hold
51,243
– – ﹤0.01% 614
2024
Q4 		$174K Hold
51,243
– – ﹤0.01% 629
2024
Q3 		$146K Hold
51,243
– – ﹤0.01% 623
2024
Q2 		$115K Hold
51,243
– – ﹤0.01% 607
2024
Q1 		$113K Hold
51,243
– – ﹤0.01% 608
2023
Q4 		$120K Hold
51,243
– – ﹤0.01% 618
2023
Q3 		$95.3K Hold
51,243
– – ﹤0.01% 615
2023
Q2 		$134K Hold
51,243
– – ﹤0.01% 617
2023
Q1 		$83.5K Hold
51,243
– – ﹤0.01% 632
2022
Q4 		$68.2K Hold
51,243
– – ﹤0.01% 644
2022
Q3 		$80K Hold
51,243
– – ﹤0.01% 627
2022
Q2 		$79K Hold
51,243
– – ﹤0.01% 629
2022
Q1 		$131K Hold
51,243
– – ﹤0.01% 640
2021
Q4 		$150K Hold
51,243
– – ﹤0.01% 664
2021
Q3 		$126K Hold
51,243
– – ﹤0.01% 657
2021
Q2 		$209K Buy
+51,243
New +$196K ﹤0.01% 662

Other funds holding XERS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

Chevy Chase Trust's XERS Position: Q3 2025 in Review

Chevy Chase Trust sold out of Xeris Biopharma Holdings (XERS) in Q3 2025, closing a stake of 51,243 shares — an estimated $239K sold.

Chevy Chase Trust first reported a position in XERS in Q2 2021 and held it in 17 quarters. The position peaked at $281K in Q1 2025. 230 funds tracked by Wall St. Rank hold XERS as of Q3 2025.

  • Chevy Chase Trust reported no remaining Xeris Biopharma Holdings position as of Q3 2025 after selling out during the quarter.
  • Chevy Chase Trust sold 51,243 Xeris Biopharma Holdings shares in Q3 2025, an estimated $239K.
  • Chevy Chase Trust first reported a position in Xeris Biopharma Holdings in Q2 2021 and held it in 17 quarters.
  • Chevy Chase Trust's Xeris Biopharma Holdings position peaked at $281K in Q1 2025.
  • 230 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q3 2025.

Based on Chevy Chase Trust's 13F filing for Q3 2025, filed 14 Nov 2025.